LeadIQ logo
Learn more at LeadIQ.com

Insights

Acquisition by Eli Lilly Sigilon Therapeutics was recently acquired by Eli Lilly for $310 million, indicating a strong financial backing and potential for collaboration with Lilly's extensive network and resources.

Cell Therapy Development Sigilon is focused on developing encapsulated-cell therapies for acute and chronic diseases, such as the innovative SIG-002 treatment for type 1 diabetes, presenting a partnership opportunity for healthcare providers and institutions.

Top Talent Recruitment Sigilon has strategically hired key personnel like Sarah Yuan as Chief Technical Operations Officer, showcasing a commitment to innovation and expertise that could open avenues for partnerships and collaborations.

Funding and Financial Stability With significant funding of $145 million and reported revenues between $10-50 million, Sigilon's financial health positions the company as a potential client for service providers or investment opportunities.

Industry Partnerships The partnership between Sigilon and Eli Lilly signifies a collaborative approach to developing functional cures, making them an attractive prospect for research institutions, biotech companies, and pharmaceutical collaborators.

Similar companies to Sigilon Therapeutics

Sigilon Therapeutics Tech Stack

Sigilon Therapeutics uses 8 technology products and services including NetSuite, Exhibit, jQuery, and more. Explore Sigilon Therapeutics's tech stack below.

  • NetSuite
    E-commerce
  • Exhibit
    Javascript Graphics
  • jQuery
    Javascript Libraries
  • core-js
    Javascript Libraries
  • Akamai Web Application Protector
    Security
  • Adobe Tag Manager
    Tag Management
  • Coupa
    Travel And Expense Management
  • Bootstrap
    UI Frameworks

Media & News

Sigilon Therapeutics's Email Address Formats

Sigilon Therapeutics uses at least 1 format(s):
Sigilon Therapeutics Email FormatsExamplePercentage
First.Last@sigilon.comJohn.Doe@sigilon.com
86%
FLast@sigilon.comJDoe@sigilon.com
12%
First@sigilon.comJohn@sigilon.com
2%

Frequently Asked Questions

Where is Sigilon Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Sigilon Therapeutics's main headquarters is located at 100 Binney St, STE 600 STE 2C Cambridge, MA 02142 US. The company has employees across 2 continents, including North AmericaEurope.

What is Sigilon Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Sigilon Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sigilon Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Sigilon Therapeutics is a publicly traded company; the company's stock symbol is SGTX.

What is Sigilon Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Sigilon Therapeutics's official website is sigilon.com and has social profiles on LinkedIn.

How much revenue does Sigilon Therapeutics generate?

Minus sign iconPlus sign icon
As of February 2024, Sigilon Therapeutics's annual revenue reached $15M.

What is Sigilon Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Sigilon Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sigilon Therapeutics have currently?

Minus sign iconPlus sign icon
As of February 2024, Sigilon Therapeutics has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer: D. P.Chief Legal Officer: M. K.Chief Technical Operations Officer: S. Y.. Explore Sigilon Therapeutics's employee directory with LeadIQ.

What industry does Sigilon Therapeutics belong to?

Minus sign iconPlus sign icon
Sigilon Therapeutics operates in the Biotechnology Research industry.

What technology does Sigilon Therapeutics use?

Minus sign iconPlus sign icon
Sigilon Therapeutics's tech stack includes NetSuiteExhibitjQuerycore-jsAkamai Web Application ProtectorAdobe Tag ManagerCoupaBootstrap.

What is Sigilon Therapeutics's email format?

Minus sign iconPlus sign icon
Sigilon Therapeutics's email format typically follows the pattern of . Find more Sigilon Therapeutics email formats with LeadIQ.

How much funding has Sigilon Therapeutics raised to date?

Minus sign iconPlus sign icon
As of February 2024, Sigilon Therapeutics has raised $145M in funding. The last funding round occurred on Dec 03, 2020 for $145M.

When was Sigilon Therapeutics founded?

Minus sign iconPlus sign icon
Sigilon Therapeutics was founded in 2015.
Sigilon Therapeutics

Sigilon Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.

Section iconCompany Overview

Headquarters
100 Binney St, STE 600 STE 2C Cambridge, MA 02142 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SGTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $145M

    Sigilon Therapeutics has raised a total of $145M of funding over 4 rounds. Their latest funding round was raised on Dec 03, 2020 in the amount of $145M.

  • $10M$50M

    Sigilon Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $145M

    Sigilon Therapeutics has raised a total of $145M of funding over 4 rounds. Their latest funding round was raised on Dec 03, 2020 in the amount of $145M.

  • $10M$50M

    Sigilon Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.